Fred Alger Management’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-737,553
| Closed | -$2.85M | – | 451 |
|
|
2024
Q4 | $2.85M | Sell |
737,553
-49,035
| -6% | -$190K | 0.01% | 299 |
|
|
2024
Q3 | $5.15M | Sell |
786,588
-146,906
| -16% | -$962K | 0.03% | 236 |
|
|
2024
Q2 | $6.77M | Sell |
933,494
-54,439
| -6% | -$395K | 0.03% | 219 |
|
|
2024
Q1 | $7.5M | Buy |
987,933
+901,372
| +1,041% | +$6.84M | 0.04% | 221 |
|
|
2023
Q4 | $394K | Sell |
86,561
-29,708
| -26% | -$135K | ﹤0.01% | 406 |
|
|
2023
Q3 | $459K | Buy |
116,269
+21,331
| +22% | +$84.3K | ﹤0.01% | 385 |
|
|
2023
Q2 | $297K | Sell |
94,938
-190,797
| -67% | -$597K | ﹤0.01% | 419 |
|
|
2023
Q1 | $1.29M | Buy |
+285,735
| New | +$1.29M | 0.01% | 372 |
|
|
2022
Q1 | – | Sell |
-175,870
| Closed | -$1.9M | – | 535 |
|
|
2021
Q4 | $1.9M | Hold |
175,870
| – | – | ﹤0.01% | 360 |
|
|
2021
Q3 | $2.03M | Buy |
+175,870
| New | +$2.03M | ﹤0.01% | 347 |
|
|
2015
Q2 | – | Sell |
-1,271
| Closed | -$604K | – | 521 |
|
|
2015
Q1 | $604K | Buy |
+1,271
| New | +$604K | ﹤0.01% | 537 |
|